These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 28681931)

  • 1. Assessments of plasma ghrelin levels in the early stages of parkinson's disease.
    Song N; Wang W; Jia F; Du X; Xie A; He Q; Shen X; Zhang J; Rogers JT; Xie J; Jiang H
    Mov Disord; 2017 Oct; 32(10):1487-1491. PubMed ID: 28681931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postprandial ghrelin response is reduced in patients with Parkinson's disease and idiopathic REM sleep behaviour disorder: a peripheral biomarker for early Parkinson's disease?
    Unger MM; Möller JC; Mankel K; Eggert KM; Bohne K; Bodden M; Stiasny-Kolster K; Kann PH; Mayer G; Tebbe JJ; Oertel WH
    J Neurol; 2011 Jun; 258(6):982-90. PubMed ID: 21181542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical correlates of serum insulin-like growth factor-1 in patients with Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
    Numao A; Suzuki K; Miyamoto M; Miyamoto T; Hirata K
    Parkinsonism Relat Disord; 2014 Feb; 20(2):212-6. PubMed ID: 24280021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leptin and ghrelin concentrations and weight loss in Parkinson's disease.
    Fiszer U; Michałowska M; Baranowska B; Wolińska-Witort E; Jeske W; Jethon M; Piaścik-Gromada M; Marcinowska-Suchowierska E
    Acta Neurol Scand; 2010 Apr; 121(4):230-6. PubMed ID: 20028343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma levels of DJ-1 as a possible marker for progression of sporadic Parkinson's disease.
    Waragai M; Nakai M; Wei J; Fujita M; Mizuno H; Ho G; Masliah E; Akatsu H; Yokochi F; Hashimoto M
    Neurosci Lett; 2007 Sep; 425(1):18-22. PubMed ID: 17720313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basal and postprandial plasma levels of PYY, ghrelin, cholecystokinin, gastrin and insulin in women with moderate and morbid obesity and metabolic syndrome.
    Zwirska-Korczala K; Konturek SJ; Sodowski M; Wylezol M; Kuka D; Sowa P; Adamczyk-Sowa M; Kukla M; Berdowska A; Rehfeld JF; Bielanski W; Brzozowski T
    J Physiol Pharmacol; 2007 Mar; 58 Suppl 1():13-35. PubMed ID: 17443025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of oral glucose on acylated and total ghrelin secretion in acromegalic patients.
    Isidro ML; Nemina R; Garcia-Buela J; Sangiao-Alvarellos S; Cordido F
    Neuro Endocrinol Lett; 2007 Oct; 28(5):596-603. PubMed ID: 17984943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ghrelin levels are suppressed and show a blunted response to oral glucose in women with polycystic ovary syndrome.
    Barber TM; Casanueva FF; Karpe F; Lage M; Franks S; McCarthy MI; Wass JA
    Eur J Endocrinol; 2008 Apr; 158(4):511-6. PubMed ID: 18362298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Children with Prader-Willi syndrome exhibit more evident meal-induced responses in plasma ghrelin and peptide YY levels than obese and lean children.
    Bizzarri C; Rigamonti AE; Luce A; Cappa M; Cella SG; Berini J; Sartorio A; Müller EE; Salvatoni A
    Eur J Endocrinol; 2010 Mar; 162(3):499-505. PubMed ID: 20019130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An FP-CIT PET comparison of the difference in dopaminergic neuronal loss in subtypes of early Parkinson's disease.
    Song IU; Chung YA; Oh JK; Chung SW
    Acta Radiol; 2014 Apr; 55(3):366-71. PubMed ID: 23943629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction in total plasma ghrelin levels following catecholamine depletion: relation to bulimic and depressive symptoms.
    Homan P; Grob S; Milos G; Schnyder U; Hasler G
    Psychoneuroendocrinology; 2013 Sep; 38(9):1545-52. PubMed ID: 23333252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma antioxidant status and motor features in de novo Chinese Parkinson's disease patients.
    Yuan Y; Tong Q; Zhang L; Jiang S; Zhou H; Zhang R; Zhang S; Xu Q; Li D; Zhou X; Ding J; Zhang K
    Int J Neurosci; 2016; 126(7):641-6. PubMed ID: 26010212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tau/α-synuclein ratio and inflammatory proteins in Parkinson's disease: An exploratory study.
    Delgado-Alvarado M; Gago B; Gorostidi A; Jiménez-Urbieta H; Dacosta-Aguayo R; Navalpotro-Gómez I; Ruiz-Martínez J; Bergareche A; Martí-Massó JF; Martínez-Lage P; Izagirre A; Rodríguez-Oroz MC
    Mov Disord; 2017 Jul; 32(7):1066-1073. PubMed ID: 28548309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid and plasma clusterin levels in Parkinson's disease.
    van Dijk KD; Jongbloed W; Heijst JA; Teunissen CE; Groenewegen HJ; Berendse HW; van de Berg WD; Veerhuis R
    Parkinsonism Relat Disord; 2013 Dec; 19(12):1079-83. PubMed ID: 23932065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ghrelin Bridges DMV Neuropathology and GI Dysfunction in the Early Stages of Parkinson's Disease.
    Liu Y; Wang W; Song N; Jiao L; Jia F; Du X; Chen X; Yan C; Jiao J; Jiao Q; Jiang H
    Adv Sci (Weinh); 2022 Oct; 9(30):e2203020. PubMed ID: 36050877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma apolipoprotein A1 associates with age at onset and motor severity in early Parkinson's disease patients.
    Swanson CR; Berlyand Y; Xie SX; Alcalay RN; Chahine LM; Chen-Plotkin AS
    Mov Disord; 2015 Oct; 30(12):1648-56. PubMed ID: 26207725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levels of IL-8 and TNF-α decrease in Parkinson's disease.
    Gupta V; Garg RK; Khattri S
    Neurol Res; 2016 Feb; 38(2):98-102. PubMed ID: 27078697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered fasting and postprandial plasma ghrelin levels in patients with liver failure are normalized after liver transplantation.
    Diz-Lois MT; Garcia-Buela J; Suarez F; Sangiao-Alvarellos S; Vidal O; Cordido F
    Eur J Endocrinol; 2010 Oct; 163(4):609-16. PubMed ID: 20616109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood Biomarkers Associated with Cognitive Decline in Early Stage and Drug-Naive Parkinson's Disease Patients.
    Santiago JA; Potashkin JA
    PLoS One; 2015; 10(11):e0142582. PubMed ID: 26566043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bradykinesia in early and advanced Parkinson's disease.
    Bologna M; Leodori G; Stirpe P; Paparella G; Colella D; Belvisi D; Fasano A; Fabbrini G; Berardelli A
    J Neurol Sci; 2016 Oct; 369():286-291. PubMed ID: 27653910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.